 |
 |
 |
 |
 |
||||||||||||||
Overactive Bladder including Nocturnal Urinary Urgency A Phase IV, 12 week Trial to evaluate the efficacy and safety of a Fesoterodine Flexible Dose regimen Why This Trial Is Important The purpose of this study is to test the safety and effectiveness of the study drug fesoterodine, compared to placebo, on nocturnal urinary urgency episodes in subjects with OAB. Fesoterodine is approved drug by the FDA for treatment of OAB. Who Can Join This Trial? Male or Female over the age of 18 with symptoms of overactive bladder for more than 3 months. Study Site and Contact Information Southeastern Research Group Please contact us if you are interested in participating in this study. |
|
|||||||||||||||
 |
 |
